InMed Pharmaceuticals INM
NASDAQ INM
$1.38 +0.01 (+1.10%)
At close: Sep 29, 2026 · 4:00 PM EDT

InMed Pharmaceuticals (INM) Research & Development (2019 - 2026)

Updated

InMed Pharmaceuticals' Research & Development came in at $805,741 for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 39.6% from $577,254 a year earlier but down 21.2% from the prior quarter.

Analysis

InMed Pharmaceuticals (INM) Research & Development (2019 - 2026) Analysis & Trends

For FY2026 (ended Jun 30, 2026), InMed Pharmaceuticals' Research & Development was $3.03 million, up 7.3% from FY2025.

  • Research & Development carries a five-year compound annual growth rate of -10.7% (FY2021 to FY2026).
  • Going back by fiscal year, Research & Development was $2.82 million in FY2025 (-12.3%), $3.22 million in FY2024 (-13.8%), $3.73 million in FY2023 (-48.8%) and $7.28 million in FY2022 (+36.4%).
  • The five-year range for quarterly Research & Development is $425,370 (fiscal Q3 2025) to $2.54 million (fiscal Q2 2022).
  • Year-over-year, Research & Development increased in three of the last eight quarters, with growth averaging 10.9%.
  • The fastest year-over-year change in Research & Development over five years came in fiscal Q2 2022 (growth of 170.5%), and the weakest in fiscal Q2 2023 (a decline of 66.4%).
  • Business Quant data shows INM's Research & Development at $1.02 million (Q3 2026), $630,636 (Q2 2026) and $581,612 (Q1 2026) in the three fiscal quarters before Q4 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Linde 217.60 Bn 200.72 Bn 4.43 Bn 37.00 Mn
2 Corning 130.50 Bn 123.63 Bn 1.63 Bn 299.00 Mn
3 Sherwin Williams 80.80 Bn 79.84 Bn 3.34 Bn -
4 Air Products & Chemicals 62.07 Bn 59.97 Bn 1.04 Bn 21.50 Mn
5 Corteva 51.85 Bn 40.65 Bn 3.66 Bn 388.00 Mn
6 LyondellBasell Industries 37.65 Bn 27.27 Bn 2.04 Bn 34.00 Mn
7 Nutrien 34.70 Bn 31.57 Bn 3.25 Bn -
8 Qnity Electronics 26.13 Bn 23.56 Bn 666.00 Mn 98.00 Mn
9 Ati 24.61 Bn 22.75 Bn 309.80 Mn -
10 InMed Pharmaceuticals 5.66 Mn 3.46 Mn - 805,741.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 805,741.00
Mar 31, 2026 1.02 Mn
Dec 31, 2025 630,636.00
Sep 30, 2025 581,612.00
Jun 30, 2025 577,254.00
Mar 31, 2025 425,370.00
Dec 31, 2024 895,176.00
Sep 30, 2024 700,145.00
Jun 30, 2024 658,869.00
Mar 31, 2024 656,764.00
Dec 31, 2023 609,791.00
Sep 30, 2023 1.29 Mn
Jun 30, 2023 623,744.00
Mar 31, 2023 878,303.00
Dec 31, 2022 851,356.00
Sep 30, 2022 1.38 Mn
Jun 30, 2022 1.50 Mn
Mar 31, 2022 1.75 Mn
Dec 31, 2021 2.54 Mn
Sep 30, 2021 1.49 Mn
API Access

InMed Pharmaceuticals Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=INM&period=max&api_key=YOUR_API_KEY